nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Secondary infection—Azathioprine—multiple sclerosis	0.0671	0.0714	CcSEcCtD
Sulfacetamide—Secondary infection—Triamcinolone—multiple sclerosis	0.0409	0.0436	CcSEcCtD
Sulfacetamide—Secondary infection—Methylprednisolone—multiple sclerosis	0.0408	0.0435	CcSEcCtD
Sulfacetamide—Secondary infection—Dexamethasone—multiple sclerosis	0.0371	0.0395	CcSEcCtD
Sulfacetamide—Secondary infection—Betamethasone—multiple sclerosis	0.0371	0.0395	CcSEcCtD
Sulfacetamide—Lupus erythematosus—Triamcinolone—multiple sclerosis	0.0323	0.0344	CcSEcCtD
Sulfacetamide—Conjunctival hyperaemia—Prednisolone—multiple sclerosis	0.0297	0.0317	CcSEcCtD
Sulfacetamide—Blood disorder—Cladribine—multiple sclerosis	0.029	0.0309	CcSEcCtD
Sulfacetamide—Conjunctival hyperaemia—Dexamethasone—multiple sclerosis	0.0248	0.0264	CcSEcCtD
Sulfacetamide—Conjunctival hyperaemia—Betamethasone—multiple sclerosis	0.0248	0.0264	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Cladribine—multiple sclerosis	0.0228	0.0242	CcSEcCtD
Sulfacetamide—Systemic lupus erythematosus—Triamcinolone—multiple sclerosis	0.0217	0.0231	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Azathioprine—multiple sclerosis	0.0185	0.0197	CcSEcCtD
Sulfacetamide—Blister—Prednisolone—multiple sclerosis	0.0181	0.0193	CcSEcCtD
Sulfacetamide—Blister—Triamcinolone—multiple sclerosis	0.0167	0.0178	CcSEcCtD
Sulfacetamide—Stinging—Prednisolone—multiple sclerosis	0.0161	0.0172	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.0159	0.0169	CcSEcCtD
Sulfacetamide—Infection—Fingolimod—multiple sclerosis	0.0152	0.0161	CcSEcCtD
Sulfacetamide—Blister—Betamethasone—multiple sclerosis	0.0151	0.0161	CcSEcCtD
Sulfacetamide—Blister—Dexamethasone—multiple sclerosis	0.0151	0.0161	CcSEcCtD
Sulfacetamide—Stinging—Triamcinolone—multiple sclerosis	0.0148	0.0158	CcSEcCtD
Sulfacetamide—Acetaminophen—CNR1—multiple sclerosis	0.0146	0.241	CrCbGaD
Sulfacetamide—Stinging—Dexamethasone—multiple sclerosis	0.0135	0.0143	CcSEcCtD
Sulfacetamide—Stinging—Betamethasone—multiple sclerosis	0.0135	0.0143	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.0134	0.0143	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.0129	0.0137	CcSEcCtD
Sulfacetamide—Erythema multiforme—Cladribine—multiple sclerosis	0.0115	0.0123	CcSEcCtD
Sulfacetamide—Chlorpropamide—SLC15A2—multiple sclerosis	0.0113	0.186	CrCbGaD
Sulfacetamide—Tolbutamide—SLC15A2—multiple sclerosis	0.011	0.181	CrCbGaD
Sulfacetamide—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.0109	0.0116	CcSEcCtD
Sulfacetamide—Pruritus—Fingolimod—multiple sclerosis	0.0108	0.0115	CcSEcCtD
Sulfacetamide—Erythema—Cladribine—multiple sclerosis	0.0106	0.0113	CcSEcCtD
Sulfacetamide—Agranulocytosis—Azathioprine—multiple sclerosis	0.0103	0.011	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Prednisolone—multiple sclerosis	0.00993	0.0106	CcSEcCtD
Sulfacetamide—Erythema multiforme—Azathioprine—multiple sclerosis	0.00936	0.00997	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.00913	0.00972	CcSEcCtD
Sulfacetamide—Oedema—Cladribine—multiple sclerosis	0.00865	0.00921	CcSEcCtD
Sulfacetamide—Infection—Cladribine—multiple sclerosis	0.0086	0.00915	CcSEcCtD
Sulfacetamide—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00832	0.00886	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.00829	0.00882	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Betamethasone—multiple sclerosis	0.00829	0.00882	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00746	0.00794	CcSEcCtD
Sulfacetamide—Pain—Cladribine—multiple sclerosis	0.0074	0.00788	CcSEcCtD
Sulfacetamide—Infection—Azathioprine—multiple sclerosis	0.00699	0.00744	CcSEcCtD
Sulfacetamide—Erythema—Mitoxantrone—multiple sclerosis	0.00697	0.00742	CcSEcCtD
Sulfacetamide—Hypersensitivity—Cladribine—multiple sclerosis	0.00637	0.00679	CcSEcCtD
Sulfacetamide—Pruritus—Cladribine—multiple sclerosis	0.00612	0.00652	CcSEcCtD
Sulfacetamide—Erythema—Prednisolone—multiple sclerosis	0.00572	0.00609	CcSEcCtD
Sulfacetamide—Oedema—Mitoxantrone—multiple sclerosis	0.00569	0.00605	CcSEcCtD
Sulfacetamide—Infection—Mitoxantrone—multiple sclerosis	0.00565	0.00602	CcSEcCtD
Sulfacetamide—Erythema—Triamcinolone—multiple sclerosis	0.00526	0.0056	CcSEcCtD
Sulfacetamide—Erythema—Methylprednisolone—multiple sclerosis	0.00525	0.00558	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00519	0.00553	CcSEcCtD
Sulfacetamide—Hypersensitivity—Azathioprine—multiple sclerosis	0.00518	0.00552	CcSEcCtD
Sulfacetamide—Pain—Mitoxantrone—multiple sclerosis	0.00486	0.00518	CcSEcCtD
Sulfacetamide—Erythema—Dexamethasone—multiple sclerosis	0.00477	0.00508	CcSEcCtD
Sulfacetamide—Erythema—Betamethasone—multiple sclerosis	0.00477	0.00508	CcSEcCtD
Sulfacetamide—Sulfamethazine—ALB—multiple sclerosis	0.00473	0.0779	CrCbGaD
Sulfacetamide—Oedema—Prednisolone—multiple sclerosis	0.00467	0.00497	CcSEcCtD
Sulfacetamide—Sulfamerazine—ALB—multiple sclerosis	0.00462	0.0761	CrCbGaD
Sulfacetamide—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.0044	0.00469	CcSEcCtD
Sulfacetamide—Oedema—Triamcinolone—multiple sclerosis	0.00429	0.00457	CcSEcCtD
Sulfacetamide—Infection—Triamcinolone—multiple sclerosis	0.00426	0.00454	CcSEcCtD
Sulfacetamide—Infection—Methylprednisolone—multiple sclerosis	0.00425	0.00453	CcSEcCtD
Sulfacetamide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00419	0.00446	CcSEcCtD
Sulfacetamide—Erythema—Prednisone—multiple sclerosis	0.00415	0.00442	CcSEcCtD
Sulfacetamide—Agranulocytosis—Methotrexate—multiple sclerosis	0.00415	0.00441	CcSEcCtD
Sulfacetamide—Pain—Prednisolone—multiple sclerosis	0.00399	0.00425	CcSEcCtD
Sulfacetamide—Oedema—Dexamethasone—multiple sclerosis	0.00389	0.00414	CcSEcCtD
Sulfacetamide—Oedema—Betamethasone—multiple sclerosis	0.00389	0.00414	CcSEcCtD
Sulfacetamide—Infection—Betamethasone—multiple sclerosis	0.00387	0.00412	CcSEcCtD
Sulfacetamide—Infection—Dexamethasone—multiple sclerosis	0.00387	0.00412	CcSEcCtD
Sulfacetamide—Erythema multiforme—Methotrexate—multiple sclerosis	0.00377	0.00401	CcSEcCtD
Sulfacetamide—Procainamide—BCHE—multiple sclerosis	0.00375	0.0619	CrCbGaD
Sulfacetamide—Pain—Triamcinolone—multiple sclerosis	0.00367	0.00391	CcSEcCtD
Sulfacetamide—Sulfamethizole—ALB—multiple sclerosis	0.00358	0.059	CrCbGaD
Sulfacetamide—Erythema—Methotrexate—multiple sclerosis	0.00347	0.0037	CcSEcCtD
Sulfacetamide—Hypersensitivity—Prednisolone—multiple sclerosis	0.00344	0.00366	CcSEcCtD
Sulfacetamide—Oedema—Prednisone—multiple sclerosis	0.00339	0.00361	CcSEcCtD
Sulfacetamide—Infection—Prednisone—multiple sclerosis	0.00337	0.00359	CcSEcCtD
Sulfacetamide—Pain—Betamethasone—multiple sclerosis	0.00333	0.00354	CcSEcCtD
Sulfacetamide—Pain—Dexamethasone—multiple sclerosis	0.00333	0.00354	CcSEcCtD
Sulfacetamide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00316	0.00337	CcSEcCtD
Sulfacetamide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00315	0.00336	CcSEcCtD
Sulfacetamide—Gliclazide—ALB—multiple sclerosis	0.00312	0.0514	CrCbGaD
Sulfacetamide—Pruritus—Triamcinolone—multiple sclerosis	0.00304	0.00323	CcSEcCtD
Sulfacetamide—Pruritus—Methylprednisolone—multiple sclerosis	0.00303	0.00322	CcSEcCtD
Sulfacetamide—Infection—Methotrexate—multiple sclerosis	0.00282	0.003	CcSEcCtD
Sulfacetamide—Pruritus—Betamethasone—multiple sclerosis	0.00275	0.00293	CcSEcCtD
Sulfacetamide—Pruritus—Dexamethasone—multiple sclerosis	0.00275	0.00293	CcSEcCtD
Sulfacetamide—Hypersensitivity—Prednisone—multiple sclerosis	0.0025	0.00266	CcSEcCtD
Sulfacetamide—Pain—Methotrexate—multiple sclerosis	0.00242	0.00258	CcSEcCtD
Sulfacetamide—Pruritus—Prednisone—multiple sclerosis	0.0024	0.00255	CcSEcCtD
Sulfacetamide—Hypersensitivity—Methotrexate—multiple sclerosis	0.00209	0.00222	CcSEcCtD
Sulfacetamide—Sulfamethoxazole—ALB—multiple sclerosis	0.00201	0.0331	CrCbGaD
Sulfacetamide—Probenecid—ALB—multiple sclerosis	0.00201	0.033	CrCbGaD
Sulfacetamide—Pruritus—Methotrexate—multiple sclerosis	0.002	0.00213	CcSEcCtD
